| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 13 May 2026 | 1 May 2026 |
| Arunjyoti Bio Ventures Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/05/2026 inter alia to consider and approve Audited Financials results for the Quarter and Year ended 31.03.2026. With reference to the earlier intimation dated 01-05-2026, we hereby inform that the Board Meeting scheduled to be held on 08-05-2026 has been postponed due to unavoidable reasons. Revised date of the Board Meeting of the company is 12-05-2026 at the registered office of the Company. The agenda as intimated earlier remains same. (As Per BSE Announcement Dated on 05.05.2026) Arunjyoti Bio Ventures Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/05/2026 ,inter alia, to consider and approve Audited Financial Results for the Quarter and Year ended 31.03.2026. (As Per BSE Announcement Dated on 12.05.2026) Audited Financial Statements for the Quarter and Year ended 31.03.2026 (As Per BSE Announcement Dated on: 13/05/2026) | ||
| Board Meeting | 3 Feb 2026 | 30 Jan 2026 |
| Arunjyoti Bio Ventures Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/02/2026 inter alia to consider and approve Un-audited financial results along with Limited Review Report for the quarter ended 31.12.2025 and any other business with the permission of the Chair. Approval of Un-audited financial results along with the Limited Review Report for the quarter ended 31.12.2025 (As per BSE Announcement dated on: 03.02.2026) | ||
| Board Meeting | 3 Nov 2025 | 27 Oct 2025 |
| Arunjyoti Bio Ventures Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/11/2025 ,inter alia, to consider and approve Un-audited Financial Results for the quarter ended 30.09.2025 Outcome (As Per Bse Announcement dated on 03/11/2025) | ||
| Board Meeting | 4 Aug 2025 | 28 Jul 2025 |
| Arunjyoti Bio Ventures Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/08/2025 inter alia to consider and approve Un-audited financial results for the quarter ended 30.06.2025 | ||
| Board Meeting | 29 May 2025 | 21 May 2025 |
| Audited Results Results for the quarter and year ended 31.03.2025 (As Per BSE Announcement Dated on 29.05.2025) | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.